NEXT MOLECULAR ANALYTICS
NPI 1760840482
Clinical Medical Laboratory in Chester, VA
NPI Status: Active since February 09, 2016
Contact Information
11601 IRON BRIDGE RD
SUITE 101
CHESTER, VA
ZIP 23831
Phone: (804) 977-6600
- Organization
- Clinical Medical Laboratory
- Accepts Insurance
- CLIA Number: 49D2104154
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 08-30-2026
About NEXT MOLECULAR ANALYTICS
This page provides the complete NPI Profile along with additional information for Next Molecular Analytics, a provider established in Chester, Virginia operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1760840482 assigned on February 2016. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 10 years ago. The provider's is doing business as Next Molecular Analytics. The authorized official of this NPI record is Mr. Thomas R Reynolds (President)
- NPI
- 1760840482
- Provider Legal Name
- NEXT BIO-RESEARCH SERVICES, LLC.
- Other Organization Name
- NEXT MOLECULAR ANALYTICS
- Other Name Type
- Doing Business As (3)
- Entity Type
- Organization
- Location Address
- 11601 IRON BRIDGE RD SUITE 101 CHESTER, VA 23831
- Location Phone
- (804) 977-6600
- Mailing Address
- 11601 IRON BRIDGE RD SUITE 101 CHESTER, VA 23831
- Mailing Phone
- (804) 977-6600
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 02-09-2016
- Last Update Date
- 02-09-2016
- Code Navigator
Establishments like Next Molecular Analytics are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Insurance Plans Accepted
According to publicly available information the provider might be accepting the following health plans from these health insurance companies:
- Blue Advantage Bronze HMO? 204 - HMO
- Blue Advantage Bronze HMO? 301 - HMO
- Blue Advantage Bronze HMO? Standard - HMO
- Blue Advantage Gold HMO? 206 - HMO
- Blue Advantage Gold HMO? 603 - HMO
- Blue Advantage Gold HMO? Standard - HMO
- Blue Advantage Plus Bronze? 303 - POS
- Blue Advantage Plus Bronze? 305 - POS
- Blue Advantage Plus Bronze? Standard - POS
- Blue Advantage Plus Gold? 203 - POS
- Blue Advantage Plus Gold? 803 - POS
- Blue Advantage Plus Gold? Standard - POS
- Blue Advantage Plus Silver? 202 - POS
- Blue Advantage Plus Silver? 605 - POS
- Blue Advantage Plus Silver? Standard - POS
- Blue Advantage Security HMO? 200 - HMO
- Blue Advantage Silver HMO? 205 - HMO
- Blue Advantage Silver HMO? 801 - HMO
- Blue Advantage Silver HMO? Standard - HMO
*Please verify directly with this provider to make sure your insurance plan is currently accepted.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
Detection test for candida species (yeast), amplified probe technique
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
This service involves the testing for COVID-19 using advanced technologies that can process multiple samples at once. It identifies different types or subtypes of the virus, including SARS-CoV-2/2019-nCoV. This test is non-CDC but adheres to the guidelines outlined in CMS-2020-01-R.
This service was performed 119 times for 103 patientsThis is a lab test that detects the presence of COVID-19 in your body. It uses a technique to amplify the virus's genetic material, either DNA or RNA, making it easier to identify. A positive result indicates an active infection.
This service was performed 127 times for 103 patientsA detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.
This service was performed 14 times for 14 patientsThis test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.
This service was performed 14 times for 14 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 117 times for 101 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 35 times for 22 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 49D2104154
- Facility Type
- Independent
- Certificate Effective Date
- August 31, 2024
- Certificate Expiration Date
- August 30, 2026
- Laboratory Director
- DAI J. LI MD PHD
- Certificate Type
- Certificate of Compliance
- Certificate Type Description
- This CLIA certificate is issued to Next Molecular Analytics after an inspection that finds the laboratory to be in compliance with all applicable CLIA requirements. This type of certificate is issued to laboratories that perform nonwaived (moderate and/or high complexity) testing.
Reviews for NEXT MOLECULAR ANALYTICS
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1760840482, we treat the final digit (2) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 58. The final step is to find the difference between that total and the next multiple of ten (60 - 58 = 2).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 58 is 60. The difference is the calculated check digit.
Other Providers at the Same Location
The following 19 providers are registered at the same or a nearby location.
CHESTER, VA 23831
CHESTER, VA 23831
CHESTER, VA 23831
CHESTER, VA 23831
CHESTER, VA 23831
CHESTER, VA 23831
CHESTER, VA 23831
CHESTER, VA 23831
CHESTER, VA 23831
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1760840482, enumerated as an "organization" on February 09, 2016.
The provider is located at 11601 IRON BRIDGE RD SUITE 101 CHESTER, VA 23831 and the phone number is (804) 977-6600.
Clinical Medical Laboratory with taxonomy code 291U00000X.
The provider might be accepting Accepts: Blue Cross and Blue Shield of Texas. Please consult your insurance carrier or call the provider to verify.
